Recent annual report for ASX: EHH included a few points about OmniInnovation Hutang 1 pre-meal diabetic drink, of which EVE has a 39% interest.
During the 2018 financial year:
-Pg. 3: Upgrade of the high speed line in the Hutang 1 production facility.
-Pg. 3: 50 of the stores have already opened, with plans to sell Hutang 1 in them.
-Pg. 55: Footnote indicating that earmarked $4m is mostly commited to the production line of Hutang 1.
Once the Chinese approval is received (if), could be rapid distribution and sales of Hutang 1, of which Omni receives royalties. Hoping it can be a nice little earner.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
-0.002(6.45%) |
Mkt cap ! $7.140M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.9¢ | $21.31K | 731.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 183001 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 325264 | 1 |
View Market Depth
| Last trade - 15.06pm 19/09/2025 (20 minute delay) ? |
| EVE (ASX) Chart |